Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Carbamazepine ...

The Carbamazepine extended-release tablets are indicated for use as an anti-convulsant drug and also for the treatment of the ...

Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA.

Extended-release morphine tablets recalled Posted: Jul 1, 2022 / 06:46 AM EDT. Updated: Jul 1, 2022 / 11:43 AM EDT. These 60mg morphine tablets are being recalled after being mislabeled as 30mg ...

The recalled lots include Morphine Sulfate 30mg Extended-Release tablets; NDC 63629-1088-01; Lot #17642; Expiration Date 11/30/2023, and Morphine Sulfate 60mg Extended-Release tablets; ...

Medicare drug plans may cover Rinvoq, but the specifics of coverage and out-of-pocket costs can differ depending on a person's specific plan.

Pharvaris' innovative approach to treating hereditary angioedema (HAE) with deucrictibant. Read here for an investment ...

Mirabegron Extended-Release Tablets USP 25mg and 50mg had annual sales of USD 2.42bn in the US (IQVIA MAT February 2024).

Hydrocodone extended-release tablets: Take the tablets once per day at the same time each day. Swallow each tablet whole with enough water to make sure it goes down easily. Do not dissolve, crush ...

Everolimus tablets for oral ... Inc. today announced that the U.S. Food and Drug Administration has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which ...

Orphenadrine Citrate 100 mg Extended Release tablets that went to customers from August 2019 through April 2021. The 1,000-count bottle lot is No. KS3939, expiration 03/2023.